David B. Agus
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
Papers in
-
- Prostate Cancer Treatment and Research 42
- Co-authors
- Parag Mallick (14 shared papers)Darren Kessner (3 shared papers)Matt Chambers (1 shared paper)Robert Burke (1 shared paper)Howard I. Scher (15 shared papers)Carlos Cordon‐Cardo (10 shared papers)Brian Higgins (8 shared papers)Mitchell E. Gross (28 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)The Prostate (6 papers)Scientific Reports (5 papers)Investigational New Drugs (3 papers)Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
David B. Agus
115 papers receiving 8.2k citations
David B. Agus's Hit Papers
Peers
Comparison fields: 5 of 174
- Oncology 1.9k
- Cancer Research 876
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 3.6k
- Spectroscopy 754
Countries citing papers authored by David B. Agus
This map shows the geographic impact of David B. Agus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Agus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Agus more than expected).
Fields of papers citing papers by David B. Agus
This network shows the impact of papers produced by David B. Agus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Agus. The network helps show where David B. Agus may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Agus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ProteoWizard: open source software for rapid proteomics tools development Hit paper breakdown → | 2008 | 1551 |
| 2 | Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Hit paper breakdown → | 2000 | 542 |
| 3 | 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. | 2002 | 373 |
| 4 | 2005 | 325 | |
| 5 | 1997 | 279 | |
| 6 | 1999 | 245 | |
| 7 | 1991 | 238 | |
| 8 | 1999 | 223 | |
| 9 | 2001 | 202 | |
| 10 | Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. | 2003 | 198 |
| 11 | 2020 | 173 | |
| 12 | Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. | 1999 | 141 |
| 13 | 2010 | 139 | |
| 14 | HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. | 2001 | 136 |
| 15 | Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. | 2000 | 131 |
| 16 | 2001 | 126 | |
| 17 | Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. | 1999 | 125 |
| 18 | 2010 | 114 | |
| 19 | 2015 | 113 | |
| 20 | Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. | 2001 | 108 |
About David B. Agus
David B. Agus is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 119 papers that have together received 8.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (42 papers), HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (11 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Cancer Genomics and Diagnostics (10 papers), Advanced Proteomics Techniques and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (876 citations), Pulmonary and Respiratory Medicine (1.7k citations), Molecular Biology (3.6k citations) and Spectroscopy (754 citations). David B. Agus has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Parag Mallick, Darren Kessner, Matt Chambers, Robert Burke, Howard I. Scher, Carlos Cordon‐Cardo, Brian Higgins, Mitchell E. Gross, David W. Golde and Charles D. Surh. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, Scientific Reports, Investigational New Drugs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.